Multiple Myeloma: Planning a Continuum of Care in 2020

Multiple Myeloma: Planning a Continuum of Care in 2020

Episodes

Specialty:

All

Year:

All

EP. 1: Frontline Triplet Therapies in Multiple Myeloma

ByKeith Stewart, MB, CHB, UHN and Princess Margaret Hospital,Natalie S. Callander, MD, University of Washington Carbone Cancer Center ,Thomas G. Martin, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Noopur Raje, MD, Massachusetts General Hospital,Peter Voorhees, MD

July 17th 2020

EP. 2: Tolerability of Triplet Therapy in Multiple Myeloma

ByKeith Stewart, MB, CHB, UHN and Princess Margaret Hospital,Natalie S. Callander, MD, University of Washington Carbone Cancer Center ,Thomas G. Martin, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Noopur Raje, MD, Massachusetts General Hospital,Peter Voorhees, MD

July 17th 2020

EP. 3: Transplant-Ineligible Multiple Myeloma

ByKeith Stewart, MB, CHB, UHN and Princess Margaret Hospital,Natalie S. Callander, MD, University of Washington Carbone Cancer Center ,Thomas G. Martin, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Noopur Raje, MD, Massachusetts General Hospital,Peter Voorhees, MD

July 17th 2020

EP. 4: Treating Transplant-Eligible and -Ineligible MM

ByKeith Stewart, MB, CHB, UHN and Princess Margaret Hospital,Natalie S. Callander, MD, University of Washington Carbone Cancer Center ,Thomas G. Martin, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Noopur Raje, MD, Massachusetts General Hospital,Peter Voorhees, MD

July 17th 2020

EP. 5: The Role of Transplant in Multiple Myeloma

ByKeith Stewart, MB, CHB, UHN and Princess Margaret Hospital,Natalie S. Callander, MD, University of Washington Carbone Cancer Center ,Thomas G. Martin, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Noopur Raje, MD, Massachusetts General Hospital,Peter Voorhees, MD

July 17th 2020

EP. 6: MRD Monitoring in Multiple Myeloma

ByKeith Stewart, MB, CHB, UHN and Princess Margaret Hospital,Natalie S. Callander, MD, University of Washington Carbone Cancer Center ,Thomas G. Martin, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Noopur Raje, MD, Massachusetts General Hospital,Peter Voorhees, MD

July 17th 2020

EP. 7: Maintenance Therapy Approaches in Multiple Myeloma

ByKeith Stewart, MB, CHB, UHN and Princess Margaret Hospital,Natalie S. Callander, MD, University of Washington Carbone Cancer Center ,Thomas G. Martin, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Noopur Raje, MD, Massachusetts General Hospital,Peter Voorhees, MD

July 17th 2020

EP. 8: Management of Relapsed/Refractory Multiple Myeloma

ByKeith Stewart, MB, CHB, UHN and Princess Margaret Hospital,Natalie S. Callander, MD, University of Washington Carbone Cancer Center ,Thomas G. Martin, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Noopur Raje, MD, Massachusetts General Hospital,Peter Voorhees, MD

July 17th 2020

EP. 9: Daratumumab With Carfilzomib in Frontline Multiple Myeloma

ByKeith Stewart, MB, CHB, UHN and Princess Margaret Hospital,Natalie S. Callander, MD, University of Washington Carbone Cancer Center ,Thomas G. Martin, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Noopur Raje, MD, Massachusetts General Hospital,Peter Voorhees, MD

July 17th 2020

EP. 10: Lenalidomide-Refractory Multiple Myeloma

ByKeith Stewart, MB, CHB, UHN and Princess Margaret Hospital,Natalie S. Callander, MD, University of Washington Carbone Cancer Center ,Thomas G. Martin, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Noopur Raje, MD, Massachusetts General Hospital,Peter Voorhees, MD

July 17th 2020

EP. 11: BOSTON Study; SVd in Relapsed/Refractory Multiple Myeloma

ByKeith Stewart, MB, CHB, UHN and Princess Margaret Hospital,Natalie S. Callander, MD, University of Washington Carbone Cancer Center ,Thomas G. Martin, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Noopur Raje, MD, Massachusetts General Hospital,Peter Voorhees, MD

July 17th 2020

EP. 12: BELLINI Trial; Venetoclax-Vd in Multiple Myeloma

ByKeith Stewart, MB, CHB, UHN and Princess Margaret Hospital,Natalie S. Callander, MD, University of Washington Carbone Cancer Center ,Thomas G. Martin, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Noopur Raje, MD, Massachusetts General Hospital,Peter Voorhees, MD

July 17th 2020

EP. 13: BCMA-Targeted Therapies in Multiple Myeloma

ByKeith Stewart, MB, CHB, UHN and Princess Margaret Hospital,Natalie S. Callander, MD, University of Washington Carbone Cancer Center ,Thomas G. Martin, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Noopur Raje, MD, Massachusetts General Hospital,Peter Voorhees, MD

July 17th 2020

EP. 14: Using Antibody-Drug Conjugates in Multiple Myeloma

ByKeith Stewart, MB, CHB, UHN and Princess Margaret Hospital,Natalie S. Callander, MD, University of Washington Carbone Cancer Center ,Thomas G. Martin, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Noopur Raje, MD, Massachusetts General Hospital,Peter Voorhees, MD

July 17th 2020

EP. 15: Development of CAR T Cells in Multiple Myeloma

ByKeith Stewart, MB, CHB, UHN and Princess Margaret Hospital,Natalie S. Callander, MD, University of Washington Carbone Cancer Center ,Thomas G. Martin, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Noopur Raje, MD, Massachusetts General Hospital,Peter Voorhees, MD

July 17th 2020

EP. 16: Differentiating among CAR T Products for Multiple Myeloma

ByKeith Stewart, MB, CHB, UHN and Princess Margaret Hospital,Natalie S. Callander, MD, University of Washington Carbone Cancer Center ,Thomas G. Martin, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Noopur Raje, MD, Massachusetts General Hospital,Peter Voorhees, MD

July 17th 2020

EP. 17: Bispecific Antibodies for Multiple Myeloma

ByKeith Stewart, MB, CHB, UHN and Princess Margaret Hospital,Natalie S. Callander, MD, University of Washington Carbone Cancer Center ,Thomas G. Martin, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Noopur Raje, MD, Massachusetts General Hospital,Peter Voorhees, MD

July 17th 2020

EP. 18: Future of BCMA-Targeted Therapies in Multiple Myeloma

ByKeith Stewart, MB, CHB, UHN and Princess Margaret Hospital,Natalie S. Callander, MD, University of Washington Carbone Cancer Center ,Thomas G. Martin, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Noopur Raje, MD, Massachusetts General Hospital,Peter Voorhees, MD

July 17th 2020

Trending on OncLive

FDA Approves Dostarlimab for dMMR/MSI-H Locally Advanced Rectal Cancer

FDA Clears TumorSight Risk, an MRI-Derived AI Recurrence Tool for HR+, HER2– Breast Cancer

Dr Cercek on the FDA Approval of Dostarlimab for dMMR/MSI-H Locally Advanced Rectal Cancer

Vilamakitug Meets OS Threshold in Phase 1/2 Refractory mCRC Trial

Weigh Benefit Against Burden: Defining Lurbinectedin’s Role in a Shifting Small Cell Lung Cancer Landscape